| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.38 | 0.02 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.36 | 0.06 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.35 | 0.01 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.34 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.21 | 2e-05 |